atopic%20dermatitis
ATOPIC DERMATITIS
Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.

Atopic%20dermatitis Patient Education

Patient Education

  • Discuss the chronic nature of atopic dermatitis, exacerbating factors and appropriate treatment options
    • Emphasize that atopic dermatitis tends to decrease with increase in age
  • Convey the goal of treatment is control rather than “cure”
  • Discuss that many factors probably contribute to flare-ups and usually a specific cause cannot be found
  • Educate the patient about proper skin care (eg bathing, hydration and use of moisturizers)
    • Patient/caregiver should be instructed to apply emollients liberally 3 minutes after taking a bath 2-3 times daily or frequently as the skin gets dry even in the absence of symptoms
    • Studies showed that correct and adequate instructions for use and application of moisturizers when done properly reduces disease severity and overall topical corticosteroids use
  • Explain potential side effects of medications when used over extended periods of time
    • Apply topical steroid 10-15 minutes after application of emollients
  • Keep fingernails trimmed short
  • Use of cotton gloves at night to limit scratching
Editor's Recommendations
Most Read Articles
5 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 4 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.